Bernard-Soulier Syndrome
A rare inherited platelet disorder marked by abnormally large platelets, low platelet counts, and a tendency toward mucocutaneous bleeding.
- Specialist hematology review
- Bleeding risk management guidance
- Genetic counseling support
- Inheritance
- Autosomal Recessive (GP1BA/GP1BB/GP9)
- Most Common In
- Diagnosed in childhood, often after bleeding episode
- Clinical Hallmark
- Giant Platelets with Low Platelet Count
- Advanced Therapies
- Platelet Transfusion, Desmopressin, Stem Cell Transplant (Severe Cases)
Condition Overview
Bernard-Soulier syndrome is a rare inherited bleeding disorder caused by mutations in the genes that encode glycoprotein Ib-IX-V (GP1BA, GP1BB, or GP9), a receptor on the platelet surface that allows platelets to stick to injured blood vessel walls. Without a properly functioning receptor, platelets fail to adhere normally at sites of vessel injury, leading to a bleeding tendency despite an adequate or even mildly reduced platelet count.
A defining laboratory feature is the presence of unusually large ('giant') platelets, often visible on a routine blood smear, combined with a mild-to-moderate reduction in platelet number โ a pattern called macrothrombocytopenia. Severity of bleeding symptoms varies between individuals and even within the same family.
Because Bernard-Soulier syndrome is rare and shares features with other inherited platelet disorders and with immune thrombocytopenia, an accurate diagnosis often requires specialized platelet function testing and genetic confirmation, ideally at a center experienced with bleeding disorders.
Types and Subtypes
Bernard-Soulier syndrome is generally described by its inheritance pattern and resulting severity rather than distinct biological subtypes.
Symptoms and Signs
Symptoms reflect impaired platelet function and typically involve bleeding from mucous membranes and skin rather than deep tissue bleeding.
Causes and Risk Factors
Bernard-Soulier syndrome is a purely genetic disorder; it is not caused by lifestyle, diet, or environmental exposures.
Diagnosis and Investigations
Diagnosis combines basic blood counts and smear findings with specialized platelet function and genetic testing.
Disease Severity Classification
Bernard-Soulier syndrome does not use a cancer-style staging system. Instead, clinicians classify severity by bleeding tendency and platelet count to guide precautions and treatment planning.
Standard Treatment Options
There is no cure for the underlying receptor defect; management focuses on preventing and controlling bleeding episodes.
Advanced and Emerging Treatment Options
For the most severe, refractory cases, options beyond standard supportive care may be considered.
Cellular Therapy
Hematopoietic stem cell transplant
Can be curative by replacing the blood-forming system with donor cells, generally reserved for severe, transfusion-refractory cases due to transplant-related risks.
Targeted Therapy
Recombinant activated factor VII
Used selectively in severe bleeding unresponsive to platelet transfusion, particularly when patients have developed antibodies against donor platelets.
Gene Therapy
Investigational gene therapy research
Early-stage research is exploring gene-based correction strategies for inherited platelet receptor disorders.
Biomarkers and Precision Medicine
Specific platelet function and genetic markers confirm diagnosis and help anticipate bleeding risk.
When a Second Opinion May Be Important
Given how rare Bernard-Soulier syndrome is, specialist review can help confirm diagnosis and plan safely around bleeding risk.
Clinical Trials and Research
Prognosis and Key Outcome Factors
Most people with Bernard-Soulier syndrome live full lives with appropriate bleeding precautions and access to specialist hematology care, though individual bleeding severity varies.
Supportive Care and Living With Bernard-Soulier Syndrome
Ongoing supportive measures help reduce bleeding episodes and prepare for situations with higher bleeding risk.
How CancerFax Helps You Explore Treatment Options
CancerFax helps patients with Bernard-Soulier syndrome access specialist hematology review, second opinions on bleeding management, and coordination for procedure planning or transplant evaluation in severe cases.
Get a free case reviewFrequently Asked Questions
It is a rare inherited platelet disorder in which a defective receptor prevents platelets from sticking properly to injured blood vessels, leading to giant platelets, a low platelet count, and a bleeding tendency.
Early signs often include easy bruising, frequent nosebleeds, and prolonged bleeding from minor cuts, sometimes first identified after a bleeding episode or unexpectedly low platelet count.
Both can cause low platelet counts, but Bernard-Soulier syndrome is an inherited receptor defect with giant platelets and abnormal platelet aggregation studies, while ITP is an acquired immune condition; specific testing distinguishes the two.
Yes, it typically follows an autosomal recessive pattern, requiring an affected gene copy from each parent for the full syndrome to occur.
There is no cure for the underlying receptor defect, though hematopoietic stem cell transplant can be curative in select severe cases; most patients are managed long-term with bleeding precautions and supportive therapies.
Options include desmopressin, antifibrinolytic medications, local measures for minor bleeding, and platelet transfusion for significant bleeding episodes or surgery.
Repeated platelet transfusions can lead to antibody formation against donor platelets, reducing the effectiveness of future transfusions, so they are generally reserved for significant bleeding or major procedures.
Yes, with advance planning that may include desmopressin, antifibrinolytics, or platelet support coordinated with a hematologist familiar with the condition.
Genetic counseling and testing of close relatives can clarify carrier status and is often recommended, especially when planning a pregnancy.
Yes. CancerFax can help coordinate medical report review, connect you with hematology specialists for a second opinion, and support planning for procedures or transplant evaluation in severe cases, including cross-border coordination where needed.
Get Expert Guidance for Bernard-Soulier Syndrome
Share your reports with our team to explore specialist review and bleeding management support.